JPRN-C000000234已完成未知
A Phase I/II Study of Carboplatin and TS-1 in Patients with Advanced Non-small Cell Lung Cancer: CJLSG-0402 - A phase I/II Study of CBDCA+TS-1 in Non-small Cell Lung Cancer
Central Japan Lung Study Group0 个研究点目标入组 32 人开始时间: 2005年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Massive pleural effusion with the incication of local therapy 2. Clinically appearent pericardial effusion 3. Serious medical complications: Uncontrolled angina pectoris, myocardial infarction within 3 months, heart failure. Uncontrolled diabetes mellitus, hypertension, infections. Contraindication for carboplatin or TS-1 use 4. Pulmonary fiblosis detectable on chest X-ray films 5. Pregnant or milk-feeding female. Intention to be pregnant in the future 6. Other clinical difficulites to this study
研究者
相似试验
未知
不适用
Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancernon small cell lung cancerJPRN-C000000054Department of Medical Oncology, Kinki University School of Medicine25
招募中
2 期
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in patients with unresectable locally advanced non-small cell lung cancernresectable locally advanced non-small cell lung cancerJPRN-UMIN000011663Dokkyo Medical University40
已完成
不适用
Phase I/II trial of carboplatin, TS-1, and concurrent radiation therapy in elderly patients with locally advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000005794ational Cancer Center Hospital East40
招募中
2 期
A Phase II Study of Carboplatin and S-1 Followed by S-1 Maintenance for Patients Who Have Squamous Cell Lung CarcinomaSquamous Cell Lung CarcinomaJPRN-UMIN000007433Central Japan Lung Study Group (CJLSG)30
招募中
1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancerocally Advanced Non-Small Cell Lung CancerJPRN-UMIN000016730Foundation for Biomedical Research and Innovation43